Pulmonx Corp. (LUNG)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Pulmonx Corp. (LUNG)
Company Performance

Current Price

as of Oct 16, 2024

$6.80

P/E Ratio

N/A

Market Cap

$266.24M

Description

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Metrics

Overview

  • HQRedwood City, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerLUNG
  • Price$6.8-2.30%

Trading Information

  • Market Cap$266.24M
  • Float90.38%
  • Average Daily Volume (1m)200,838
  • Average Daily Volume (3m)289,785
  • EPS-$1.50

Company

  • Revenue$76.58M
  • Rev Growth (1yr)20.87%
  • Net Income-$15.33M
  • Gross Margin73.65%
  • EBITDA Margin-64.98%
  • EBITDA-$13.51M
  • EV$188.29M
  • EV/Revenue2.46
  • P/EN/A
  • P/S3.46
  • P/B2.63
Documents